CD8A and colorectal carcinoma: However, based on TCGA dataset analysis, a small subset of patients among MSI-Low/MSS-CRC cases exhibiting a high CD8+ T cell infiltrate and an upregulation of IFN-γ could benefit from immunotherapies (98).